KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Share-based Compensation (2016 - 2026)

Pacific Biosciences Of California has reported Share-based Compensation over the past 16 years, most recently at $9.6 million for Q4 2025.

  • For Q4 2025, Share-based Compensation fell 40.2% year-over-year to $9.6 million; the TTM value through Dec 2025 reached $41.7 million, down 41.34%, while the annual FY2025 figure was $41.7 million, 41.34% down from the prior year.
  • Share-based Compensation for Q4 2025 was $9.6 million at Pacific Biosciences Of California, down from $11.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $22.7 million in Q1 2022 and troughed at $7.5 million in Q3 2022.
  • A 5-year average of $15.8 million and a median of $17.6 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: soared 388.71% in 2021 and later tumbled 60.22% in 2022.
  • Year by year, Share-based Compensation stood at $18.9 million in 2021, then fell by 5.19% to $18.0 million in 2022, then decreased by 7.64% to $16.6 million in 2023, then fell by 3.32% to $16.0 million in 2024, then tumbled by 40.2% to $9.6 million in 2025.
  • Business Quant data shows Share-based Compensation for PACB at $9.6 million in Q4 2025, $11.0 million in Q3 2025, and $11.9 million in Q2 2025.